FDA Drug Application (022026) for AMLODIPINE BESYLATE by SYNTHON PHARMS

Back to FDA Applications sponsored by SYNTHON PHARMS

Application Number022026
Product Number001
FormTABLET, ORALLY DISINTEGRATING;ORAL
DosageEQ 2.5MG BASE
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAMLODIPINE BESYLATE
Active IngredientAMLODIPINE BESYLATE

Active IngredientCount
List of drugs with Active Ingredient AMLODIPINE BESYLATE21


Back to FDA Applications sponsored by SYNTHON PHARMS